Oral Kaposi sarcoma A associated with severe alveolar bone loss: Case report and review of the literature

Journal of Periodontology

Volumn 74, Issue 11, 2003, Pages 1668-1675

  Lausten, Leonard L ^a   Ferguson, Brett L ^b   Barker, Bruce F ^b   Cobb, Charles M ^b  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b Dept of Oral/Maxillofacial Surgery ^*

Author keywords

Acquired immune deficiency syndrome complications; Alveolar bone loss pathogenesis; Kaposi sarcoma complications

Indexed keywords

CYTOKINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALVEOLAR BONE; ARTICLE; CANCER RADIOTHERAPY; CASE REPORT; CONSULTATION; DENTAL SURGERY; DENTURE; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; MALE; MAXILLARY SINUS; MEDICAL RECORD; MOUTH TUMOR; ORAL BIOPSY; OSTEOLYSIS; PATHOGENESIS; PERFORATION; PERIODONTAL DISEASE;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ALVEOLAR BONE LOSS; FURCATION DEFECTS; GINGIVAL NEOPLASMS; HUMANS; MALE; MAXILLA; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL POCKET; SARCOMA, KAPOSI; TOOTH MOBILITY;

EID: 0348218919     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2003.74.11.1668     Document Type: Article

References (61)

1. Köbner H. General knowledge on sarcomas and especially skin sarcoma (in German). Arch Dermatol Syph 1869;1:369-381.
2. Kaposi M. Idiopathic multiple pigmented sarcomas of skin (in German). Arch Dermatol Syph 1872;3: 265-273.
3. Dorffel J. Histogenesis of multiple idopathic hemorrhagic sarcoma of Kaposi. (Review on the subject on 356 cases up to 1932 and 16 cases personally). Arch Dermatol Syph 1932;26:608-634.
4. Beral V. Epidemiology of Kaposi's sarcoma. Cancer Surv 1991;10:5-22.
5. Safai B, Diaz B, Schwartz J. Malignant neoplasms associated with human immunodeficiency virus infection. CA Cancer J Clin 1992;42:74-95.
6. Dezube BJ. New therapies for the treatment of AIDS-related Kaposi sarcoma. Curr Opin Oncol 2000;12: 445-449.
7. Flaitz CM, Nichols CM, Hicks MJ. Role of intralesional vinblastine administration in treatment of intraoral Kaposi's sarcoma in AIDS. Eur J Cancer B Oral Oncol 1995;31B:280-285.
8. Beral V, Peterman TA, Berkelman RL, Jaffe HW. Kaposi's sarcoma among persons with AIDS: A sexually transmitted disease? Lancet 1990;335:123-128.
9. Jacobson LP, Munoz A, Fox R, et al. Incidence of Kaposi's sarcoma in a cohort of homosexual men infected with human immunodeficiency virus type I. J Acquir Immune Defic Syndr 1990;3(Suppl):S24-S31.
10. Rosenberg RA, Schneider KL, Cohen NL. Head and neck presentations of acquired immunodeficiency syndrome. Laryngoscope 1984;94:401-405.
11. Reichert PA, Langford-Kuntz A, Pohle H-D. Epidemic orofacial Kaposi's sarcoma (eKS) - Report of 124 cases. Eur J Cancer B Oral Oncol 1993;29B:187-189.
12. Ficarra G, Berson AM, Silverman Jr S, et al. Kaposi's sarcoma of the oral cavity: A study of 134 patients with a review of the pathogenesis, epidemiology, clinical aspects and treatment. Oral Surg Oral Med Oral Pathol 1988;66:543-550.
13. Scully C, Laskaris G, Pindborg J, Porter SR, Reichart P. Oral manifestations of HIV infection and their management. I. More common lesions. Oral Surg Oral Med Oral Pathol 1991;71:150-166.
14. Langford A, Pohle H-D, Reichart P. Primary intraosseous AIDS-associated Kaposi's sarcoma. Report of two cases with initial jaw involvement. Int J Maxillofac Surg 1991;20:366-368.
15. Nichols CM, Flaitz CM, Hicks MJ. Treating Kaposi's lesions in the HIV-infected patient. J Am Dent Assoc 1993;124:78-84.
16. Narani N, Epstein JB. Classifications of oral lesions in HIV infection. J Clin Periodontol 2001;28:137-145.
17. Nichols CM, Flaitz CM, Hicks MJ. Primary intraosseous Kaposi's sarcoma of the maxilla in human immunodeficiency virus infection: Review of literature and report of case. J Oral Maxillofac Surg 1995;53: 325-329.
18. Kleinegger CL, Sarubin D. Intraoral Kaposi's sarcoma associated with alveolar bone erosion. Mississippi Dent Assoc J 1996;52:14-15.
19. Laor Y, Schwartz RA. Epidemiologic aspects of American Kaposi's sarcoma. J Surg Oncol 1979;12:299-303.
20. Biggar RJ, Horm J, Fraumeni JFJ, Greene MH, Goedert JJ. Incidence of Kaposi's sarcoma and mycosis fungoides; in the United States including Puerto Rico, 1973-1981. J Natl Cancer Inst 1984;73:89-94.
21. Ross RK, Casagrande JT, Dworsky RL, Levine A, Mack T. Kaposi's sarcoma in Los Angeles, California. J Natl Cancer Inst 1985;75:1101-1105.
22. Wabinga HR, Parkin DM, Wabwire-Mangen F, Mugerwa JW. Cancer in Kampala, Uganda, in 1989-91: Changes in incidence in the era of AIDS. Int J Cancer 1993;54: 26-36.
23. Bassett MT, Chokunonga E, Mauchaza B, Levy L, Ferlay J, Parkin DM. Cancer in the African population of Harare, Zimbabwe, 1990-1992. Int J Cancer 1995;63:29-36.
24. Peterman TA, Jaffe HW, Friedman-Kien AE, Weiss RA. The aetiology of Kaposi's sarcoma. Cancer Surv 1991; 10:23-37.
25. Trattner A, Hodak E, David M, Sandbank M. The appearance of Kaposi sarcoma during corticosteroid therapy. Cancer 1993;72:1179-1183.
26. Bendsoe N, Dictor M, Blomberg J, Agren S, Merk K. Increased incidence of Kaposi sarcoma in Sweden before the AIDS epidemic. Eur J Cancer 1990;26:699-702.
27. Klepp O, Dahl O, Stenwig JT. Association of Kaposi's sarcoma and prior immunosuppressive therapy: A 5-year study of Kaposi's sarcoma in Norway. Cancer 1978;42:2626-2630.
28. Penn I. Kaposi's sarcoma in transplant recipients. Transplantation 1997;64:669-673.
29. Wang, C-YE, Schroeter AL, Daniel WP. Acquired immunodeficiency syndrome-related Kaposi's sarcoma. Mayo Clin Proc 1995;70:869-879.
30. Cottoni F, Montesu MA. Kaposi's sarcoma classification: A problem not yet defined. Int J Dermatol 1996; 35:480-483.
31. Iscovich J, Boffetta P, Franceschi S, Azizi E, Sarid R. Classic Kaposi sarcoma: Epidemiology and risk factors. Cancer 2000;88:500-517.
32. Greenspan D, Greenspan JS. Oral mucosal manifestations of AIDS. Dermatol Clin 1987;5:733-737.
33. Epstein JB, Scully C. HIV infection: Clinical features and treatment of thirty-three homosexual men with Kaposi's sarcoma. Oral Surg Oral Med Oral Pathol 1991;71:38-41.
34. Langford A. Gingival and periodontal alterations associated with infection with human immunodeficiency virus. Quintessence Int 1989;25:375-387.
35. Krown SE. Acquired immunodeficiency syndrome-associated Kaposi's sarcoma. Med Clin North Am 1997;81:471-494.
36. Petit JC, Ripamonti U, Hille J. Progressive changes of Kaposi's sarcoma of the gingiva and palate. J Periodontol 1986;57:159-163.
37. Flaitz CM, Nichols CM, Hicks MJ. An overview of the oral manifestations of AIDS-related Kaposi's sarcoma. Compendium 1995;16:136-144.
38. Way DL, Witte MH, Fiala M, et al. Endothelial transdifferentiated phenotype and cell-cycle kinetics of AIDS-associated Kaposi sarcoma cells. Lymphology 1993; 26:79-89.
39. Corbeil J, Evans LA, Vasak E, Cooper DA, Penny R. Culture and properties of cells derived from Kaposi sarcoma. J Immunol 1991;146:2972-2976.
40. Thompson EW, Nakamura S, Shima TB, et al. Supernatants of acquired immunodeficiency syndrome-related Kaposi's sarcoma cells induce endothelial cell chemotaxis and invasiveness. Cancer Res 1991;51:2670-2676.
41. Wittek AE, Mitchell CD, Armstrong GR, et al. Propagation and properties of Kaposi's sarcoma-derived cell lines obtained from patients with AIDS: Similarity of cultured cells to smooth muscle cells. AIDS 1991;5:1458-1493.
42. Ensoli B, Barillari G, Salahuddin SZ, Gallo RC, Wong-Staal F. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 1990;344:84-86.
43. Ensoli B, Gendelman R, Markham P, et al. Synergy between basic fibroblast growth factor and HIV-1 tat protein in induction of Kaposi's sarcoma. Nature 1994; 371:674-680.
44. Ledergerber B, Telenti A, Egger M. Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: Prospective cohort study. Br Med J 1999;319:23-24.
45. Epstein JB. Management of oral Kaposi's sarcoma and a proposal for clinical staging. Oral Dis 1997;3(Suppl. 1):S124-S128.
46. Kirova YM, Belembaogo E, Frikha H, et al. Radiotherapy in the management of epidemic Kaposi's sarcoma: A retrospective study of 643 cases. Radiother Oncol 1998;46:19-22.
47. Mitsuyasu RT. Update on the pathogenesis and treatment of Kaposi sarcoma. Curr Opin Oncol 2000;12: 174-180.
48. Harris JW, Reed TA. Kaposi's sarcoma in AIDS: The role of radiation therapy. Front Radiat Ther Oncol 1985;19:126-132.
49. Watkins EB, Findlay P, Gelmann E, Lane HC, Zabell A. Enhanced mucosal reactions in AIDS patients receiving oropharyngeal irradiation. Int J Radiat Oncol Biol Phys 1987;13:1403-1408.
50. Miller RC, Martenson JA, Petersen IA. Radiotherapy for oral manifestations of Kaposi's sarcoma. Mayo Clin Proc 1996;71:213.
51. Tappero JW, Conant MA, Wolfe SF, et al. Kaposi's sarcoma. Epidemiology, pathogenesis, histology, clinical spectrum, staging criteria and therapy. J Am Acad Dermatol 1993;28:371-395.
52. Boudreauz AA, Smith LL, Cosby CD, et al. Intralesional vinblastine for cutaneous Kaposi's sarcoma associated with acquired immunodeficiency syndrome. J Am Acad Dermatol 1993;28:61-65.
53. Epstein JB, Scully C. Intralesional vinblastine for oral Kaposi's sarcoma in HIV infection. Lancet 1989;11: 1100-1110.
54. McCormick SU. Intralesional vinblastine injections for the treatment of oral Kaposi's sarcoma: Report of 10 patients with 2-year follow-up. J Oral Maxillofac Surg 1996;54:583-587.
55. Depuy J, Price M, Lynch G, Bruce S, Schwartz M. Intralesional interferon-alpha and zidovudine in epidemic Kaposi's sarcoma. J Am Acad Dermatol 1993; 28:966-972.
56. Sulis E, Floris C, Sulis ML, et al. Interferon administered intralesionally in skin and oral cavity lesion in heterosexual drug addicted patients with AIDS-related Kaposi sarcoma. Eur J Cancer Clin Oncol 1989;25: 756-761.
57. Muzyka BC, Glick M. Sclerotherapy for the treatment of nodular intraoral Kaposi's sarcoma in patients with AIDS. New Engl J Med 1993;328:210-221.
58. Lucatoro FM, Sapp JP. Treatment of oral Kaposi's sarcoma with a sclerosing agent in AIDS patients: A preliminary study. Oral Surg Oral Med Oral Pathol 1993; 75:192-198.
59. Von Roenn JH, Krown SE, Benson CA, et al. Management of AIDS-associated Kaposi's sarcoma: A multidisciplinary perspective. Oncol 1998;12(Suppl 3):1-24.
60. Gill PS, Wernz J, Scadden DT, et al. Randomized phase III trial of liposomal daunorubicin (DaunoXome) versus doxorubicin, bleomycin, vincristine (ABV) in AIDS-related Kaposi's sarcoma. J Clin Oncol 1998;16:3369-3374.
61. Stewart S, Jablonowski H, Goebel FD, et al. Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. J Clin Oncol 1998; 16:683-691.